Calcium bioavailability and kinetics of calcium ascorbate and calcium acetate in rats.
The objective was to investigate the bioavailability and mechanism of calcium absorption of calcium ascorbate (ASC) and calcium acetate (AC). A series of studies was performed in adult Sprague-Dawley male rats. In the first study, each group of rats (n = 10/group) was assigned to one of the five test meals labeled with (45)Ca: (i) 25 mg calcium as heated ASC or (ii) unheated ASC, (iii) 25 mg calcium as unheated AC, (iv) 3.6 mg Ca as unheated ASC, or (v) unheated AC. Femur uptake indicated better calcium bioavailability from ASC than AC at both calcium loads. A 5-min heat treatment partly reduced bioavailability of ASC. Kinetic studies were performed to further investigate the mechanism of superior calcium bioavailability from ASC. Two groups of rats (n = 10/group) received oral doses of 25 mg Ca as ASC or AC. Each dose contained 20 micro Ci (45)Ca. Two additional groups of rats (n = 10/group) received an intravenous injection (iv) of 10 micro Ci (45)Ca after receiving an unlabeled oral dose of 25 mg calcium as ASC or AC. Sequential blood samples were collected over 48 hrs. Urine and fecal samples were collected every 12 hrs for 48 hrs and were analyzed for total calcium and (45)Ca content. Total calcium and (45)Ca from serum, urine, and feces were fitted by a compartment kinetics model with saturable and nonsaturable absorption pathways by WinSAAM (Windows-based Simulation Analysis and Modeling). The difference in calcium bioavailability between the two salts was due to differences in saturable rather than passive intestinal absorption and not to endogenous secretion or calcium deposition rate. The higher bioavailability of calcium ascorbate was due to a longer transit time in the small intestine compared with ASC.
Cai
Jianwei
J
Department of Foods and Nutrition, Purdue University, West Lafayette, Indiana 47907, USA.
Zhang
Qinmin
Q
Wastney
Meryl E
ME
Weaver
Connie M
CM
D000042:Absorption; D000085:Acetates / Q000493:pharmacokinetics*; D000284:Administration, Oral; D000818:Animals; D001205:Ascorbic Acid / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D001682:Biological Availability; D002118:Calcium / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics* / Q000652:urine; D017610:Calcium Compounds; D002132:Calcium Radioisotopes; D005243:Feces / Q000737:chemistry; D005269:Femur / Q000378:metabolism; D007275:Injections, Intravenous; D008297:Male; D008954:Models, Biological; D051381:Rats; D017207:Rats, Sprague-Dawley
D000085:Acetates; D017610:Calcium Compounds; D002132:Calcium Radioisotopes; D001205:Ascorbic Acid; D002118:Calcium; C120662:calcium acetate